This trial looks at whether CGM or BGM help people with Type 2 diabetes keep their blood sugar in the right range.
- Type 2 Diabetes
1 Primary · 4 Secondary · Reporting Duration: Three (3) months
Awards & Highlights
2 Treatment Groups
Blood Glucose Monitoring (BGM)
1 of 2
Continuous Glucose Monitoring (CGM)
1 of 2
150 Total Participants · 2 Treatment Groups
Primary Treatment: Continuous Glucose Monitoring (CGM) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the current enrollment rate for this trial?
"Affirmative, clinicaltrials.gov displays that this experiment is searching for participants. It was opened on the 22nd of September 2022 and was last amended on the 29th of September 2022. The study aims to enrol 150 patients at one site." - Anonymous Online Contributor
Are there any current opportunities for enrolment in this experiment?
"Affirmative. Clinicaltrials.gov specifies that this study is actively enrolling participants, with the initial posting of September 22nd 2022 and most recent update on September 29th 2022. The trial aims to sign up a total of 150 patients in one test site." - Anonymous Online Contributor